The launch marks the culmination of an international conference, but the real story was the life it celebrated: a Kagay-anon social scientist who spent 54 yearsThe launch marks the culmination of an international conference, but the real story was the life it celebrated: a Kagay-anon social scientist who spent 54 years

Xavier U launches fund honoring one of Mindanao’s pioneering social scientists

2026/03/07 10:00
5 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

CAGAYAN DE ORO, Philippines – For decades, Dr. Magdalena Cabaraban trained generations of students in research methods, survey analysis, statistics, and gender studies, instilling in them the principle that scholarship must not just serve journals but serve communities.

Over a year after the pioneering Kagay-anon social scientist passed away, the Jesuit-run Xavier University-Ateneo de Cagayan opened a new chapter in the life of social science in Mindanao.

One of its conference rooms buzzed with conversation, papers rustling, and cameras clicking as academics, policymakers, and family members gathered for the launch of the Dr. Magdalena Canag Cabaraban Memorial Fund on Friday, March 6.

The ceremony marked the culmination of the two-day 2026 International Scientific Conference of the Philippine Population Association (PPA), but the real story was the life it celebrated: a Kagay-anon social scientist who spent 54 years showing that data is most powerful when it serves people.

Cabaraban’s career was a blueprint for social research with impact, shaping the study of society in the Philippines. A magna cum laude graduate of Xavier-Ateneo, she earned a PhD in Sociology focusing on population studies and deepened her expertise in social and economic statistics at George Washington University.

She also contributed as a fellow with the World Health Organization, blending rigorous quantitative methods with a relentless focus on human welfare.

Her research addressed some of the Philippines’ most pressing social challenges: maternal and child health, gender equality, migration, inter-ethnic relations, and climate resilience. But her influence extended beyond numbers. She championed the idea that social science is most meaningful when it empowers the vulnerable.

“Research and teaching are my major undertakings,” she once wrote, reflecting on the craft that became her life’s work.

She was born in Leon, Iloilo on July 22, 1938, and she died in Cagayan de Oro on November 25, 2024, the city where she and her husband Henry raised a family and where she spent the greater part of her years. 

She was 86 when cardiac arrest claimed her, after a long struggle with a heart condition that had required angioplasty. Death in her case was both an end and a punctuation to a life lived with purpose and rigor, the kind that leaves behind more than memories and sets a standard.

Her husband Henry hailed from Northern Mindanao, from Balingasag in Misamis Oriental, east of Cagayan de Oro. They met in Manila, where she was an academic scholar at Manuel L. Quezon University and he was renting a space at her uncle’s house. It was not a glamorous beginning, but it was the start of a partnership – a marriage – that would endure decades.

They settled in Cagayan de Oro, where she pursued her education at Xavier-Ateneo, earning her degree even as all five of their children had already been born.

Her daughter Sharina said that as a student of Sociology, the late Jesuit priest Francis Madigan, founder of the Research Institute for Mindanao Culture (RIMCU), had noticed her brilliance. He invited her to work as a data encoder at a time when computers were enormous and unwieldy machines. She was soon absorbed as a full-time staff member at RIMCU, beginning a career that would leave an indelible mark on social science in Cagayan de Oro and elsewhere in Mindanao.

The memorial fund in her honor aims to continue that legacy, supporting aspiring social scientists who share her vision of evidence-informed policy making with a human touch.

Dr. Chona Echavez, RIMCU director at Xavier-Ateneo and PPA president, said the fund will support research work of undergraduates and graduates along interests close to Cabaraban’s heart.

Echavez said the memorial fund, which will be managed by RIMCU and Xavier-Ateneo’s Department of Sociology and Anthropology, will also help young researchers participate in conferences and other capacity-building activities to make them more competent and better equipped.

Don Antonio Velez, assistant professor at the university’s sociology and anthropology department, said, “This fund is a tribute to a woman who believed that data is most powerful when it is used to serve the vulnerable. By launching it during the PPA International Scientific Conference, we ensure her commitment inspires researchers across the globe.”

The launch was the highlight of the 2026 International Scientific Conference, themed “Intersections: Population, Environment, and Climate Resilience in the Philippines,” which brought together local and international demographers, academics, and policymakers to discuss population trends, climate challenges, and the nation’s demographic dividend.

For the family of Cabaraban, who attended alongside colleagues and scholars, the memorial fund was more than a financial endowment. It celebrated a life spent asking not just, “What does the data say?” but, “How can this knowledge serve the community?”

Through this fund, her legacy will not only be remembered in textbooks and journals, but lived daily in the work of social scientists who continue to follow her example: merging numbers with nuance, statistics with social conscience, and research with real-world impact. – Rappler.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09